Clinical Trial Update: A Study of Real-world Outcomes Among Patients Treated With Ribociclib

View source ↗

Summary

This entry reports a completed real-world outcomes study of ribociclib in patients with metastatic breast cancer. The sponsor is Novartis Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ribociclib (ribociclib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Metastatic Breast Cancer | Status: COMPLETED